Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release
- PMID: 11358458
- DOI: 10.1006/exnr.2001.7672
Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release
Abstract
Both ionotropic and metabotropic glutamate receptors have been implicated in the pathogenesis of neuronal injury. Activation of group I metabotropic glutamate receptors (mGluR) exacerbates neuronal cell death, whereas inhibition is neuroprotective. However, the mechanisms involved remain unknown. Activation of group I mGluR modulates multiple signal transduction pathways including stimulation of phosphoinositide hydrolysis, potentiation of NMDA receptor activity, and release of arachidonic acid. Here we demonstrate that whereas activation of group I mGluR by (S)-3,5-dihydroxyphenylglycine (DHPG) potentiates NMDA-induced currents and intracellular calcium increases in rat cortical neuronal cultures, partial effects of group I mGluR activation or inhibition on neuronal injury induced by oxygen-glucose deprivation remain despite NMDA receptor blockade. DHPG stimulation also increases basal arachidonic acid release from rat neuronal-glial cultures and potentiates injury-induced arachidonic acid release in these cultures. Thus, activation of group I mGluR may exacerbate neuronal injury through multiple mechanisms, which include positive modulation of NMDA receptors and enhanced release of arachidonic acid.
Copyright 2001 Academic Press.
Similar articles
-
Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.Br J Pharmacol. 2005 Jun;145(4):527-34. doi: 10.1038/sj.bjp.0706219. Br J Pharmacol. 2005. PMID: 15821750 Free PMC article.
-
mGluR modulation of post-traumatic neuronal death: role of NMDA receptors.Neuroreport. 1997 Jul 28;8(11):2561-6. doi: 10.1097/00001756-199707280-00028. Neuroreport. 1997. PMID: 9261827
-
Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures.Eur J Neurosci. 1998 Sep;10(9):2848-55. doi: 10.1111/j.1460-9568.1998.00291.x. Eur J Neurosci. 1998. PMID: 9758154
-
Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?Ann N Y Acad Sci. 2005 Aug;1053:55-73. doi: 10.1196/annals.1344.006. Ann N Y Acad Sci. 2005. PMID: 16179509 Review.
-
Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders.Drug News Perspect. 2003 Oct;16(8):513-22. doi: 10.1358/dnp.2003.16.8.829350. Drug News Perspect. 2003. PMID: 14668949 Review.
Cited by
-
Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis.Mol Brain. 2013 Feb 14;6:9. doi: 10.1186/1756-6606-6-9. Mol Brain. 2013. PMID: 23406666 Free PMC article.
-
The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease.Neurotox Res. 2005;7(1-2):125-41. doi: 10.1007/BF03033782. Neurotox Res. 2005. PMID: 15639804 Review.
-
Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders.Neurotherapeutics. 2009 Jan;6(1):94-107. doi: 10.1016/j.nurt.2008.10.038. Neurotherapeutics. 2009. PMID: 19110202 Free PMC article. Review.
-
Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.Br J Pharmacol. 2005 Jun;145(4):527-34. doi: 10.1038/sj.bjp.0706219. Br J Pharmacol. 2005. PMID: 15821750 Free PMC article.
-
Hypoxia-ischemia and retinal ganglion cell damage.Clin Ophthalmol. 2008 Dec;2(4):879-89. doi: 10.2147/opth.s3361. Clin Ophthalmol. 2008. PMID: 19668442 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources